Study: Stress Triggers RA Flares Through the IL-6 Pathway

Psychological stress triggers rheumatoid arthritis (RA) flares by activating a specific inflammatory pathway involving brown adipose tissue and the signaling protein interleukin-6 (IL-6), according to a study published October 16, 2026, in Science Advances. Researchers found that this mechanism can reactivate joint inflammation even in cases where the disease had previously entered remission.

Stress-Induced Inflammation Findings:

• Stress activates the sympathetic nervous system and brown adipose tissue (BAT), causing the release of IL-6.
• IL-6 stimulates fibroblast-like synoviocytes in the joints to produce CXCL1, which recruits neutrophils to the site.
• Blocking the CXCR2 receptor or using a β3-adrenergic receptor antagonist significantly reduced stress-triggered joint swelling.

While the link between emotional distress and worsening RA symptoms has been observed clinically for years, the biological bridge between the mind and the joint remained poorly understood. The research team, led by Assistant Professor Shigeru Tanaka and Professor Hiroshi Nakajima of Chiba University, collaborated with Asahi General Hospital and International University of Health and Welfare Narita Hospital to isolate the exact cellular triggers of these flares.

Brown Adipose Tissue Releases IL-6 During Stress

The study utilized a mouse model where arthritis was allowed to reach a remission-like state before the animals were subjected to restraint stress. Through tissue analysis and immune-cell profiling, the researchers traced a pathway from the brain to the joints. They discovered that psychological stress activates the sympathetic nervous system, which in turn stimulates brown adipose tissue—a specialized type of body fat primarily responsible for heat production.

Once activated, this brown adipose tissue releases interleukin-6 (IL-6), a potent inflammatory signaling protein, into the bloodstream. This discovery suggests that the pathogenesis of a stress-induced flare is not limited to the immune cells typically associated with autoimmune disorders. As Assistant Professor Tanaka explained, stress activates processes in other tissues that contribute to the return of joint inflammation.

CXCL1 Attracts Neutrophils to Drive Joint Swelling

The researchers identified that the circulating IL-6 targets fibroblast-like synoviocytes, which are specialized cells located in the synovial tissue surrounding the joints. When these cells respond to IL-6, they produce a chemokine called CXCL1. This protein acts as a chemical beacon that attracts neutrophils—a type of white blood cell—into the joint space.

The resulting accumulation of neutrophils drives the reactivation of inflammation and physical swelling. To verify this pathway, the team blocked the CXCR2 receptor, which is the protein that responds to CXCL1. This intervention significantly reduced the occurrence of stress-triggered arthritis in the mouse models. Treating the mice with a β3-adrenergic receptor antagonist reduced plasma IL-6 levels, lowered CXCL1 expression, and decreased neutrophil accumulation in the joints.

“Our findings suggest that targeting the stress-responsive pathways may offer a future therapeutic strategy that acts without broadly suppressing the immune system,” notes Prof. Nakajima.

The team examined whether this biological pathway exists in human RA patients. They examined a variant of the ADRB3 gene, which affects how cells respond to stress-related hormones.

Clinical Implications for Remission Maintenance

For patients in remission, this suggests that psychological stressors may reactivate joint inflammation by utilizing the BAT-IL-6-CXCL1 axis.

The identification of the β3-adrenergic receptor and the CXCR2 receptor as key nodes in this pathway provides a potential roadmap for new pharmaceuticals. Unlike broad immunosuppressants, which can leave patients vulnerable to infection, targeting the stress-responsive pathway could theoretically prevent flares without compromising the overall immune system.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.